TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study of the DASH Diet in Not-Well-Controlled Adult Asthma
Brief Summary: Dietary intervention efficacy trials are distinctly lacking in asthma research. This pilot study aims to provide effect size estimates and justification, clinical trial and intervention feasibility data, and procedural materials for a full-scale randomized controlled trial that will determine the efficacy and mechanisms of action of the Dietary Approaches to Stop Hypertension (DASH)-a recommended dietary pattern based on proven cardiovascular benefits-as adjunct therapy to standard care for adults with uncontrolled asthma.


Options:
A: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: DASH Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary Approaches to Stop Hypertension dietary pattern | Intervention Type: BEHAVIORAL; Name: Dietary Approaches to Stop Hypertension dietary pattern; Assigned to Arm(s): DASH Intervention
B: Arm Label: Esomeprazole; Type: EXPERIMENTAL; Interventions: Drug: Esomeprazole | Arm Label: Placebo for esomeprazoe; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo proton pump inhibitor | Intervention Type: DRUG; Name: Esomeprazole; Assigned to Arm(s): Esomeprazole | Intervention Type: DRUG; Name: Placebo proton pump inhibitor; Assigned to Arm(s): Placebo for esomeprazoe
C: Arm Label: Integrative Medicine; Type: EXPERIMENTAL; Interventions: Behavioral: Integrative Medicine | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Integrative Medicine; Assigned to Arm(s): Integrative Medicine
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Aspirin, Drug: Vitamin E | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Vitamin E, Behavioral: Placebo | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Aspirin, Behavioral: Placebo | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): 1, 3 | Intervention Type: DRUG; Name: Vitamin E; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Placebo; Assigned to Arm(s): 2, 3, 4

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Gomco Versus Mogen: Which is Best? A Randomized Controlled Trial: The GMRT Study.
Brief Summary: The purpose of this study is to compare two commonly used circumcision clamps (Gomco and Mogen) to see which results in less neonatal pain.


Options:
A: Arm Label: Group M; Type: EXPERIMENTAL; Interventions: Procedure: recorded maternal voice | Arm Label: Group S; Type: ACTIVE_COMPARATOR; Interventions: Procedure: recorded stranger's voice | Intervention Type: PROCEDURE; Name: recorded maternal voice; Assigned to Arm(s): Group M | Intervention Type: PROCEDURE; Name: recorded stranger's voice; Assigned to Arm(s): Group S
B: Arm Label: Vibration Group; Type: EXPERIMENTAL; Interventions: Device: a vibrating device | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: a vibrating device; Assigned to Arm(s): Vibration Group
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: pillow | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: pillow; Assigned to Arm(s): 1
D: Arm Label: Gomco Circumcision Clamp; Type: ACTIVE_COMPARATOR; Interventions: Device: Gomco Circumcision Clamp | Arm Label: Mogen Circumcision Clamp; Type: ACTIVE_COMPARATOR; Interventions: Device: Mogen Circumcision Clamp | Intervention Type: DEVICE; Name: Gomco Circumcision Clamp; Assigned to Arm(s): Gomco Circumcision Clamp | Intervention Type: DEVICE; Name: Mogen Circumcision Clamp; Assigned to Arm(s): Mogen Circumcision Clamp

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Sildenafil on Pulmonary Arterial Pressure in Patients With Heart Failure With Preserved Ejection Fraction ( HFpEF) and Pulmonary Hypertension
Brief Summary: Aim of the study is to investigate whether Sildenafil treatment results in a reduction of pulmonary artery pressure without decrease of cardiac output (CO) and in improvement of exercise capacity in patients with heart failure with preserved ejection fraction (HFpEF) with pulmonary hypertension ( PH).


Options:
A: Arm Label: Riociguat (Adempas, BAY63-2521) up to 2.5 mg_IDT; Type: EXPERIMENTAL; Interventions: Drug: Riociguat (Adempas, BAY63-2521), Drug: Sildenafil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Sildenafil | Intervention Type: DRUG; Name: Riociguat (Adempas, BAY63-2521); Assigned to Arm(s): Riociguat (Adempas, BAY63-2521) up to 2.5 mg_IDT | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Sildenafil; Assigned to Arm(s): Placebo, Riociguat (Adempas, BAY63-2521) up to 2.5 mg_IDT
B: Arm Label: Sildenafil; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sildenafil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sildenafil; Assigned to Arm(s): Sildenafil | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Sildenafil; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sildenafil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sildenafil; Assigned to Arm(s): Sildenafil | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Intervention Type: DRUG; Name: Bosentan and Sildenafil; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Self-Management Support in Primary Care
Brief Summary: Anxiety, Depression and Somatoform disorders are highly prevalent in primary care. Very often these conditions remain undiscovered and/or untreated.

In order to ease this urgent health care problem in the future, the investigators conduct a cluster-randomized controlled trial, implementing a tandem working cooperation between a nurse practitioner (Counseling Assistant - CA) and a general practitioner (GP) on-site its own practise.

The CA's task is to enhance the patients abilities to engage in a better self-management of their psychological symptoms and complaints, to enhance self-efficacy and empower the patients to tackle problems of daily living.


Options:
A: Arm Label: Psychosocial Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Psychosocial Counseling | Arm Label: Usual Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Psychosocial Counseling; Assigned to Arm(s): Psychosocial Counseling | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducational counseling | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Relaxation response training | Intervention Type: BEHAVIORAL; Name: Relaxation response training; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Psychoeducational counseling; Assigned to Arm(s): 1
C: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): Experimental Group
D: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Recommendation of care (letter to general practitioner [GP]); Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Transcranial Direct Current Stimulation Paired With Robotic Arm Therapy on Recovery of Upper Extremity Motor Function in Stroke Patients
Brief Summary: The purpose of this study is to evaluate if multiple therapy sessions of Transcranial Direct Current Stimulation (tDCS non-invasive brain stimulation) combined with robotic arm therapy lead to a greater functional recovery in upper limb mobility after stroke than that provided by robotic arm therapy alone.


Options:
A: Arm Label: Higher-intensity RT group; Type: EXPERIMENTAL; Interventions: Device: RT, Behavioral: Conventional rehabilitation (CR) | Arm Label: Lower-intensity RT group; Type: EXPERIMENTAL; Interventions: Device: RT, Behavioral: Conventional rehabilitation (CR) | Arm Label: Conventional rehabilitation (CR) group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional rehabilitation (CR) | Intervention Type: DEVICE; Name: RT; Assigned to Arm(s): Higher-intensity RT group, Lower-intensity RT group | Intervention Type: BEHAVIORAL; Name: Conventional rehabilitation (CR); Assigned to Arm(s): Conventional rehabilitation (CR) group, Higher-intensity RT group, Lower-intensity RT group
B: Arm Label: sham-tDCS + UE robot-assisted therapy; Type: SHAM_COMPARATOR; Interventions: Device: sham-tDCS + UE robot-assisted therapy | Arm Label: real-tDCS + UE robot-assisted therapy; Type: EXPERIMENTAL; Interventions: Device: real-tDCS + UE robot-assisted therapy | Intervention Type: DEVICE; Name: real-tDCS + UE robot-assisted therapy; Assigned to Arm(s): real-tDCS + UE robot-assisted therapy | Intervention Type: DEVICE; Name: sham-tDCS + UE robot-assisted therapy; Assigned to Arm(s): sham-tDCS + UE robot-assisted therapy
C: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Behavioral: Together in Movement and Exercise (TIME) Program | Arm Label: Wait-listed Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Together in Movement and Exercise (TIME) Program; Assigned to Arm(s): Experimental Group
D: Arm Label: tDCS + robotic arm therapy; Type: EXPERIMENTAL; Interventions: Device: Transcranial Direct Current Stimulation (tDCS) | Arm Label: tDCS sham + robotic arm therapy; Type: PLACEBO_COMPARATOR; Interventions: Device: Placebo sham | Intervention Type: DEVICE; Name: Transcranial Direct Current Stimulation (tDCS); Assigned to Arm(s): tDCS + robotic arm therapy | Intervention Type: DEVICE; Name: Placebo sham; Assigned to Arm(s): tDCS sham + robotic arm therapy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Transcranial Direct Current Stimulation Paired With Robotic Arm Therapy on Recovery of Upper Extremity Motor Function in Stroke Patients
Brief Summary: The purpose of this study is to evaluate if multiple therapy sessions of Transcranial Direct Current Stimulation (tDCS non-invasive brain stimulation) combined with robotic arm therapy lead to a greater functional recovery in upper limb mobility after stroke than that provided by robotic arm therapy alone.


Options:
A: Arm Label: Real; Type: ACTIVE_COMPARATOR; Interventions: Device: transcranial direct current stimulation tDCS, Device: transcranial magnetic stimulation TMS | Arm Label: sham; Type: PLACEBO_COMPARATOR; Interventions: Device: transcranial direct current stimulation tDCS, Device: transcranial magnetic stimulation TMS | Intervention Type: DEVICE; Name: transcranial direct current stimulation tDCS; Assigned to Arm(s): Real, sham | Intervention Type: DEVICE; Name: transcranial magnetic stimulation TMS; Assigned to Arm(s): Real, sham
B: Arm Label: tDCS + robotic arm therapy; Type: EXPERIMENTAL; Interventions: Device: Transcranial Direct Current Stimulation (tDCS) | Arm Label: tDCS sham + robotic arm therapy; Type: PLACEBO_COMPARATOR; Interventions: Device: Placebo sham | Intervention Type: DEVICE; Name: Transcranial Direct Current Stimulation (tDCS); Assigned to Arm(s): tDCS + robotic arm therapy | Intervention Type: DEVICE; Name: Placebo sham; Assigned to Arm(s): tDCS sham + robotic arm therapy
C: Arm Label: Anodal tDCS; Type: EXPERIMENTAL; Interventions: Device: Anodal transcranial direct current stimulation | Arm Label: Cathodal tDCS; Type: EXPERIMENTAL; Interventions: Device: Cathodal transcranial direct current stimulation | Arm Label: Bilateral tDCS; Type: EXPERIMENTAL; Interventions: Device: Bilateral transcranial direct current stimulation | Arm Label: Sham tDCS; Type: SHAM_COMPARATOR; Interventions: Device: Sham transcranial direct current stimulation | Intervention Type: DEVICE; Name: Anodal transcranial direct current stimulation; Assigned to Arm(s): Anodal tDCS | Intervention Type: DEVICE; Name: Cathodal transcranial direct current stimulation; Assigned to Arm(s): Cathodal tDCS | Intervention Type: DEVICE; Name: Bilateral transcranial direct current stimulation; Assigned to Arm(s): Bilateral tDCS | Intervention Type: DEVICE; Name: Sham transcranial direct current stimulation; Assigned to Arm(s): Sham tDCS
D: Arm Label: hemiplegic patient; Type: EXPERIMENTAL; Interventions: Device: transcranial Direct current stimulation | Arm Label: patient control; Type: SHAM_COMPARATOR; Interventions: Device: transcranial Direct current stimulation | Intervention Type: DEVICE; Name: transcranial Direct current stimulation; Assigned to Arm(s): hemiplegic patient, patient control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Spinal Cord Stimulation in the Irritable Bowel Syndrome - a Randomized Cross-over Trial
Brief Summary: To elucidate Spinal Cord Stimulation (SCS) as treatment for IBS. An SCS system with a 4-polar electrode at the T5-8 level is implanted. In a randomized, cross-over study design, active stimulation is compared to a period without stimulation, with an ensuing tailing stimulation period, twice as long. Patients recorded average pain level, pain attacks, number of diarrheas and global quality of life. At the end of the study patients can choose to retain their SCS stimulation system or have it removed.

The outcome of the present trial will show whether SCS is a useful treatment of IBS. The long-term follow-up will show the continuous amelioration of SCS over at least six months.


Options:
A: Arm Label: Active Lead (AL); Type: ACTIVE_COMPARATOR; Interventions: Device: Nevro Senza System (HF10 Therapy) | Arm Label: Sham Lead (SL); Type: SHAM_COMPARATOR; Interventions: Device: Nevro Senza System (HF10 Therapy) | Intervention Type: DEVICE; Name: Nevro Senza System (HF10 Therapy); Assigned to Arm(s): Active Lead (AL), Sham Lead (SL)
B: Arm Label: Study sequence A; Type: EXPERIMENTAL; Interventions: Device: Proclaim™ Elite 5: Burst - Washout - Sham | Arm Label: Study sequence B; Type: EXPERIMENTAL; Interventions: Device: Proclaim™ Elite 5: Sham - Washout - Burst | Intervention Type: DEVICE; Name: Proclaim™ Elite 5: Burst - Washout - Sham; Assigned to Arm(s): Study sequence A | Intervention Type: DEVICE; Name: Proclaim™ Elite 5: Sham - Washout - Burst; Assigned to Arm(s): Study sequence B
C: Intervention Type: DRUG; Name: pregabalin; Assigned to Arm(s): N/A
D: Arm Label: Early off-stimulation (group B); Type: OTHER; Interventions: Device: Spinal Cord Stimultion (SCS), Device: Spinal cord nerve stimulation | Arm Label: Early on-stimulation (group A); Type: OTHER; Interventions: Device: Spinal Cord Stimultion (SCS), Device: Spinal cord nerve stimulation | Intervention Type: DEVICE; Name: Spinal Cord Stimultion (SCS); Assigned to Arm(s): Early off-stimulation (group B), Early on-stimulation (group A) | Intervention Type: DEVICE; Name: Spinal cord nerve stimulation; Assigned to Arm(s): Early off-stimulation (group B), Early on-stimulation (group A)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Spinal Cord Stimulation in the Irritable Bowel Syndrome - a Randomized Cross-over Trial
Brief Summary: To elucidate Spinal Cord Stimulation (SCS) as treatment for IBS. An SCS system with a 4-polar electrode at the T5-8 level is implanted. In a randomized, cross-over study design, active stimulation is compared to a period without stimulation, with an ensuing tailing stimulation period, twice as long. Patients recorded average pain level, pain attacks, number of diarrheas and global quality of life. At the end of the study patients can choose to retain their SCS stimulation system or have it removed.

The outcome of the present trial will show whether SCS is a useful treatment of IBS. The long-term follow-up will show the continuous amelioration of SCS over at least six months.


Options:
A: Arm Label: Study sequence A; Type: EXPERIMENTAL; Interventions: Device: Proclaim™ Elite 5: Burst - Washout - Sham | Arm Label: Study sequence B; Type: EXPERIMENTAL; Interventions: Device: Proclaim™ Elite 5: Sham - Washout - Burst | Intervention Type: DEVICE; Name: Proclaim™ Elite 5: Burst - Washout - Sham; Assigned to Arm(s): Study sequence A | Intervention Type: DEVICE; Name: Proclaim™ Elite 5: Sham - Washout - Burst; Assigned to Arm(s): Study sequence B
B: Intervention Type: DEVICE; Name: Medtronic Manufactured Spinal Cord Stimulators; Assigned to Arm(s): N/A
C: Arm Label: Burst-SCS/sham SCS; Type: OTHER; Interventions: Device: Burst-SCS, Device: Sham SCS | Arm Label: Sham SCS/Burst-SCS; Type: OTHER; Interventions: Device: Burst-SCS, Device: Sham SCS | Intervention Type: DEVICE; Name: Burst-SCS; Assigned to Arm(s): Burst-SCS/sham SCS, Sham SCS/Burst-SCS | Intervention Type: DEVICE; Name: Sham SCS; Assigned to Arm(s): Burst-SCS/sham SCS, Sham SCS/Burst-SCS
D: Arm Label: Early off-stimulation (group B); Type: OTHER; Interventions: Device: Spinal Cord Stimultion (SCS), Device: Spinal cord nerve stimulation | Arm Label: Early on-stimulation (group A); Type: OTHER; Interventions: Device: Spinal Cord Stimultion (SCS), Device: Spinal cord nerve stimulation | Intervention Type: DEVICE; Name: Spinal Cord Stimultion (SCS); Assigned to Arm(s): Early off-stimulation (group B), Early on-stimulation (group A) | Intervention Type: DEVICE; Name: Spinal cord nerve stimulation; Assigned to Arm(s): Early off-stimulation (group B), Early on-stimulation (group A)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Spinal Cord Stimulation in the Irritable Bowel Syndrome - a Randomized Cross-over Trial
Brief Summary: To elucidate Spinal Cord Stimulation (SCS) as treatment for IBS. An SCS system with a 4-polar electrode at the T5-8 level is implanted. In a randomized, cross-over study design, active stimulation is compared to a period without stimulation, with an ensuing tailing stimulation period, twice as long. Patients recorded average pain level, pain attacks, number of diarrheas and global quality of life. At the end of the study patients can choose to retain their SCS stimulation system or have it removed.

The outcome of the present trial will show whether SCS is a useful treatment of IBS. The long-term follow-up will show the continuous amelioration of SCS over at least six months.


Options:
A: Arm Label: Study sequence A; Type: EXPERIMENTAL; Interventions: Device: Proclaim™ Elite 5: Burst - Washout - Sham | Arm Label: Study sequence B; Type: EXPERIMENTAL; Interventions: Device: Proclaim™ Elite 5: Sham - Washout - Burst | Intervention Type: DEVICE; Name: Proclaim™ Elite 5: Burst - Washout - Sham; Assigned to Arm(s): Study sequence A | Intervention Type: DEVICE; Name: Proclaim™ Elite 5: Sham - Washout - Burst; Assigned to Arm(s): Study sequence B
B: Arm Label: Early off-stimulation (group B); Type: OTHER; Interventions: Device: Spinal Cord Stimultion (SCS), Device: Spinal cord nerve stimulation | Arm Label: Early on-stimulation (group A); Type: OTHER; Interventions: Device: Spinal Cord Stimultion (SCS), Device: Spinal cord nerve stimulation | Intervention Type: DEVICE; Name: Spinal Cord Stimultion (SCS); Assigned to Arm(s): Early off-stimulation (group B), Early on-stimulation (group A) | Intervention Type: DEVICE; Name: Spinal cord nerve stimulation; Assigned to Arm(s): Early off-stimulation (group B), Early on-stimulation (group A)
C: Arm Label: Burst spinal cord stimulation (SCS); Type: EXPERIMENTAL; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Arm Label: sham spinal cord stimulation (SCS); Type: SHAM_COMPARATOR; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Intervention Type: PROCEDURE; Name: Burst Spinal Cord Stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS) | Intervention Type: PROCEDURE; Name: Sham spinal cord stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS)
D: Arm Label: Monocolumn spinal cord stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: comparison of spinal cord stimulation | Arm Label: Multicolumn spinal cord stimulation; Type: EXPERIMENTAL; Interventions: Device: comparison of spinal cord stimulation | Intervention Type: DEVICE; Name: comparison of spinal cord stimulation; Assigned to Arm(s): Monocolumn spinal cord stimulation, Multicolumn spinal cord stimulation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-center, Randomized, Double-blind, Three-arm, 16 Week, Adaptive Phase III Clinical Study to Investigate the Efficacy and Safety of LAS41008 vs LASW1835 and vs Placebo in Patients With Moderate to Severe Chronic Plaque Psoriasis
Brief Summary: The aim of the study is to evaluate the efficacy and safety of LAS41008 in comparison to active control and placebo in patients with moderate to severe chronic plaque psoriasis


Options:
A: Arm Label: LAS41008; Type: EXPERIMENTAL; Interventions: Drug: LAS41008 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: LASW1835; Type: ACTIVE_COMPARATOR; Interventions: Drug: LASW1835 | Intervention Type: DRUG; Name: LAS41008; Assigned to Arm(s): LAS41008 | Intervention Type: DRUG; Name: LASW1835; Assigned to Arm(s): LASW1835 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: CP 690,550 5 mg BID+Placebo BIW; Type: EXPERIMENTAL; Interventions: Drug: CP 690,550 5 mg | Arm Label: CP 690,550 10 mg BID+Placebo BIW; Type: EXPERIMENTAL; Interventions: Drug: CP 690,550 10 mg | Arm Label: Placebo BID+Etanercept 50 mg BIW; Type: ACTIVE_COMPARATOR; Interventions: Biological: Etanercept 50 mg | Arm Label: Placebo BID+Placebo BIW; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: CP 690,550 5 mg; Assigned to Arm(s): CP 690,550 5 mg BID+Placebo BIW | Intervention Type: DRUG; Name: CP 690,550 10 mg; Assigned to Arm(s): CP 690,550 10 mg BID+Placebo BIW | Intervention Type: BIOLOGICAL; Name: Etanercept 50 mg; Assigned to Arm(s): Placebo BID+Etanercept 50 mg BIW | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo BID+Placebo BIW
C: Intervention Type: DRUG; Name: adalimumab; Assigned to Arm(s): N/A
D: Arm Label: 80 mg ixekizumab Dosing Regimen 1; Type: EXPERIMENTAL; Interventions: Drug: 80 mg ixekizumab Dosing Regimen | Arm Label: 80 mg ixekizumab Dosing Regimen 2; Type: EXPERIMENTAL; Interventions: Drug: 80 mg ixekizumab Dosing Regimen | Arm Label: 80 mg ixekizumab Dosing Regimen 3; Type: EXPERIMENTAL; Interventions: Drug: 80 mg ixekizumab Dosing Regimen | Arm Label: 50 mg etanercept; Type: ACTIVE_COMPARATOR; Interventions: Drug: 50 mg etanercept | Arm Label: Placebo for ixekizumab; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: 80 mg ixekizumab Dosing Regimen; Assigned to Arm(s): 80 mg ixekizumab Dosing Regimen 1, 80 mg ixekizumab Dosing Regimen 2, 80 mg ixekizumab Dosing Regimen 3 | Intervention Type: DRUG; Name: 50 mg etanercept; Assigned to Arm(s): 50 mg etanercept | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo for ixekizumab

Answer: A